Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Melanin’s Ability to Maintain Radioprotection Examined

By LabMedica International staff writers
Posted on 07 Sep 2011
Sun worshipers have long known that melanin in their skin cells provides protection from the damage caused by visible and ultraviolet light. More...
More recent studies have shown that melanin, which is produced by multitudes of organisms, also provides some species with protection from ionizing radiation.

In certain microbes, in particular some organisms from near the former nuclear reactor facilities in Chernobyl (Ukraine), melanin has even been linked to increased growth in the presence of ionizing radiation.

Research at the US Department of Energy’s Savannah River National Laboratory (SRNL; Aiken, SC, USA), in collaboration with the Albert Einstein College of Medicine (Bronx, NY, USA), has provided clues into the electrochemical mechanism that gives the complex polymer known as melanin its long-term radioprotective properties, with an objective of using that knowledge to develop materials that mimic those natural properties.

An article in the August 2011 issue of the journal Bioelectrochemistry described how the researchers established that ionizing radiation interacts with melanin to alter its oxidation-reduction potential, resulting in electric current production.

Radiation causes damage by stripping away electrons from its target. “Over time, as melanin is bombarded with radiation and electrons are knocked away, you would expect to see the melanin become oxidized, or bleached out, and lose its ability to provide protection,” said Dr. Charles Turick, science fellow with SRNL, “but that’s not what we’re seeing. Instead, the melanin continuously restores itself.”

The investigator’s research took them a step closer to clarifying that self-restoration process. They demonstrated that melanin could receive electrons, countering the oxidizing effects of the gamma radiation. The work showed, for the first time, that constant exposure of melanin to gamma radiation results in electric current production.

Mimicking that capability would be beneficial, for example, in the space industry, where satellites and other equipment are exposed to high levels of radiation for long spans of time. “Looking at materials, a constantly gamma radiation-oxidized electrode consisting in part of melanin would continuously accept electrons, thereby resulting in a current response,” Dr. Turick said. “If we could understand how that works, we could keep that equipment working for a very long time.”


Related Links:
Energy’s Savannah River National Laboratory
Albert Einstein College of Medicine





Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.